Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
What is your preferred method of lesion interrogation for intermediate left main coronary artery stenosis?
Answer from: at Academic Institution
I typically use a multimodality approach including iFR or FFR (using typical cut offs) and IVUS using cutoff of MLA < 6.0 mm2.
Sign in or Register to read more
19079
Related Questions
Do you recommend transitioning from ticagrelor-aspirin DAPT to ticagrelor monotherapy after 1 month in patients with acute coronary syndrome and average bleeding risk post-PCI to reduce the risk of bleeding?
How soon after an elective, uncomplicated coronary intervention would you feel comfortable having a patient travel by air?
What has been your experience with Coronary CTA with FFR results and its ability to accurately predict epicardial CAD on diagnostic LHC?
For SVG graft stenting, do you consider routinely embolic protection devices (EPD), and do you factor lesion location (prox vs distal) for decision making?
What are your top takeaways from ACC 2024?
How do you decide between manual pressure versus opting for a specific vascular closure device at the conclusion of a femoral access case?
How would you proceed with V-A ECMO cannulation (Venous cannula) on a patient with massive PE who has an IVC filter with high thrombus burden?
How do you approach revascularization in patients over 75 years with NSTEMI, given recent evidence from the SENIOR-RITA trial that an invasive strategy does not significantly reduce cardiovascular events compared to a conservative strategy?
Would you recommend normal saline for pre- and post-LHC hydration in patients with CKD stage III to IV with reduced LV systolic function, and if so, what is a reasonable amount of volume?
Do you recommend routine use of protamine for hemostasis at the end of a transfemoral TAVI?